


Searching News Database: teplizumab
HSMN NewsFeed - 24 Oct 2019
Provention Bio Announces PRV-031 (Teplizumab) Granted PRIME Designation by the European Medicines Agency
Provention Bio Announces PRV-031 (Teplizumab) Granted PRIME Designation by the European Medicines Agency
HSMN NewsFeed - 12 Aug 2013
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
HSMN NewsFeed - 6 May 2008
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
